Novo is losing India’s weight-loss market to Eli Lilly. How does it redeem itself? (opens in new tab)
As Novo prepares to lose market exclusivity in India, it sets its sights on the healthcare system, partnering with Healthifyme, buying hospitals, and investing in biotech
Read the original article